Composition of 1,3,4-selenadiazole containing compounds with pharmacological activity
申请人:HANGZHOU JENNIFER BIOTECH CO., LTD
公开号:US10975048B2
公开(公告)日:2021-04-13
The invention belongs to the field of biomedical research involving the 1,3,4-selenyldiazo derivatives that have cell protective activity. Because there are not so many heterocyclic selenium compounds, we synthesized a new type of selenium analog of BPTES. As the isoacceptor of BPTES, the compounds have antitumor activity, anti-oxidation and cell protection function. Currently many drugs contain the thiodiazo motif, so synthesis of selenyldiazo functional group could further optimize these drugs and are important in new drug development and application.
本发明属于生物医学研究领域,涉及具有细胞保护活性的 1,3,4-硒基二偶氮衍生物。由于杂环硒化合物不多,我们合成了一种新型的 BPTES 硒类似物。作为 BPTES 的等位受体,这些化合物具有抗肿瘤活性、抗氧化和细胞保护功能。目前,许多药物都含有硫代偶氮基团,因此硒基偶氮官能团的合成可以进一步优化这些药物,在新药开发和应用中具有重要意义。